To evaluate the effect of exogenous ISG15 on ovarian cancer growth, ALST cells, which secreted lowest levels of endogenous ISG15, were treated with two different physiological concentrations of ISG15 (0.5 and 2.5 ng/mL). The gene discussed is ISG15; the disease is ovarian carcinoma.